In AML cells, YTHDC1 requires m6A for liquid–liquid phase separation to form nuclear YTHDC1–m6A condensates, protecting m6A–mRNAs from degradation via the PAXT complex and exosome‐associated pathways, thereby maintaining mRNA stability and regulating cancer cell survival and differentiation [151]. The gene discussed is YTHDC1; the disease is cancer.